Use of HbA1c in predicting progression to diabetes in French men and women: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1619-1625

  Droumaguet, Celine ^a   Balkau, Beverley ^a,b   Simon, Dominique ^a,b,c   Caces, Emile ^d   Tichet, Jean ^d   Charles, Marie Aline ^a,b   Eschwege, Eveline ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Institut Regional pour la Sante   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; FRANCE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BLOOD; DIET RESTRICTION; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FEMALE; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33746458530     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc05-2525     Document Type: Article

References (30)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
5. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
6. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803, 2002
7. Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J, Ganiats TG, Ginsberg HN, Kahn R, Nwankwo R, Rewers M, Schlessinger L, Stern M, Vinicor F, Zinman B: Prevention or delay of type 2 diabetes. Diabetes Care 27 (Suppl. 1):S47-S54, 2004
8. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285:2109-2113, 2001
9. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Cockram CS: The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 35 (Pt. 1):62-67, 1998
10. 1c in the Diabetes Control and Complications Trial. Diabetes Care 25:275-278, 2002
11. Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L: Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population: the Telecom Study. Diabetologia 32:864-869, 1989
12. Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE: Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values. Arch Intern Med 164:1627-1632, 2004
13. Barr RG, Nathan DM, Meigs JB, Singer DE: Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137:263-272, 2002
14. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D: Biological variation of glycohemoglobin. Clin Chem 48:1116-1118, 2002
15. Little RR, England JD, Wiedmeyer HM, Madsen RW, Pettitt DJ, Knowler WC, Goldstein DE: Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance. Diabetologia 37:252-256, 1994
16. Ko GT, Chan JC, Tsang LW, Cockram CS: Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 23:1770-1773, 2000
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
18. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989
19. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a non parametric approach. Biometrics 44:837-845, 1988
20. McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH, Knowler WC: Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328, 1994
21. Peters AL, Davidson MB, Schriger DL, Hasselblad V: A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels: Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 276:1246-1252, 1996
22. Davidson MB, Schriger DL, Peters AL, Lorber B: Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281:1203-1210, 1999
23. Davidson MB: Tests of glycemia. Ann Intern Med 138:517, 2003 [author reply 138:517, 2003]
24. Balkau B, Eschwege E, Tichet J, Marre M: Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R). Diabetes Metab 23:428-434, 1997
25. Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H: Epidemiology of diabetes in metropolitan France. Diabetes Metab 26 (Suppl. 6):11-24, 2000
26. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20:1859-1862, 1997
27. Biolam: Les actes de biologie remboursés en 2001 et 2002 par le Régime Général d'assurance maladie. Available from http://www.ameli.fr/244/DOC/1531/article.html. Accessed 16 May 2005
28. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 26:881-885, 2003
29. Miedema K: Towards worldwide standardisation of HbA1c determination. Diabetologia 47:1143-1148, 2004
30. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee: 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of hypertension meeting. Hypertension 22:392-403, 1993